umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Safety and Efficacy Outcomes in Heavily and Non-heavily Pretreated Patients With Recurrent Ovarian Cancer (ROC) After Single-agent Trabectedin Treatment - Pooled Analysis of Phase II Trials
Show others and affiliations
2011 (English)Conference paper, Published paper (Refereed)
Place, publisher, year, edition, pages
Oxford: Pergamon , 2011. Vol. 47, S528-S529 p.
Series
European Journal of Cancer, ISSN 0959-8049 ; Vol. 47 Suppl. 1
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-49259DOI: 10.1016/S0959-8049(11)72092-5ISI: 000295752801818OAI: oai:DiVA.org:umu-49259DiVA: diva2:455291
Conference
European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, Sweden, September 23-27 2011
Available from: 2011-11-09 Created: 2011-11-04 Last updated: 2011-11-14Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Boman, Kurt
By organisation
Department of Public Health and Clinical Medicine
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 48 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf